A Study of Intravenous Acetaminophen for Small Bowel Obstruction

Overview

About this study

The purpose of this study is to assess the effectiveness of IV Acetaminophen in decreasing pain as measured by a pain scale of subjective pain reported by patients and measured by nurses, that ranges from 0-10 compared to the same pain scale with usual care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Small bowel obstruction diagnosed by radiographic study; and
  • Abdominal pain on admission.
  • Nothing per mouth diet.
  • The ability to give appropriate consent or have an appropriate representative available to do so.

Exclusion Criteria:

  • Known liver failure or cirrhosis.
  • Acetaminophen toxicity on admission.
  • Known acetaminophen allergy.
  • Alcohol intoxication on admission.
  • History of substance abuse.
  • Creatinine clearance < 30 (or Creatinine level > 2).
  • Liver transplant recipients.
  • Ileus on admission.
  • Admitted for surgical intervention for SBO.
  • Admitted for venting Gastric tube placement.
  • On chronic opioid therapy (defined as use of opioid on daily or near daily basis within previous 45 days (both long acting and short acting).
  • Presentation without abdominal pain on admission.
  • Already hospitalized for other reasons and develop SBO while at the hospital.
  • Pregnant women.
  • Unable to provide informed consent.

Eligibility last updated 6/1/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Tatjana Gavrancic, M.D.

Open for enrollment

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available
.
CLS-20548880

Mayo Clinic Footer